Ras interacts with Raf-1 and stimulates its kinase activity, which results in activation of the mitogenactivated protein (MAP) kinase cascade. It has been proposed that the main function of Ras in Raf-1 activation is to recruit Raf-1 to the plasma membrane, where a separate activation event such as phosphorylation takes place. Here, we examined the activities of various mutants of human Ha-Ras to induce membrane translocation of Raf-1 and to activate Raf-1 in vivo. Overexpression of an activator region mutant Ha-Ras V45E in COS7 cells induced membrane translocation of Raf-1 as eectively as wild-type Ha-Ras. However, the activity of this mutant to activate Raf-1 and extracellular signalregulated kinase-2 (ERK2) was attenuated by approximately 70% compared to that of wild-type Ha-Ras. The decrease in the speci®c activity was further demonstrated by measuring the activity of the Ha-Ras V45E -associated Raf-1 puri®ed from the membrane fraction. These results imply that the association of Ras with Raf-1 has another important consequence, presumably dependent on the interaction between its activator region and Raf-1, than the simple recruitment of Raf-1 to the plasma membrane.
Introduction
Ras protein is a plasma membrane-associated small guanine nucleotide-binding protein that cycles between a GTP-bound active and a GDP-bound inactive form, and plays a critical role in intracellular signal transduction regulating cell growth and differentiation. In mammalian cells, Ras interacts with Raf-1 and stimulates its kinase activity, which results in activation of the mitogen-activated protein (MAP) kinase cascade including MAP kinase kinase/ERK kinase (MEK) and extracellular signal-regulated kinase (ERK) (reviewed in Avruch et al., 1994; Daum et al., 1994) . Although the precise mechanism of Raf-1 activation by Ras remains to be clari®ed, Ras was proposed to function as a vehicle which carries Raf-1 to the plasma membrane (Leevers et al., 1994; Stokoe et al., 1994) , where a separate activation event, such as tyrosine phosphorylation, takes place (Dent et al., 1995) . This was based on the ®nding that arti®cial targeting of Raf-1 to the plasma membrane in vivo caused Rasindependent activation of Raf-1 (Leevers et al., 1994; Stokoe et al., 1994) . Although v-Src, when overexpressed, is known to phosphorylate and activate Raf-1 synergistically with Ras (Williams et al., 1992; Fabian et al., 1993 Fabian et al., , 1994 , a putative protein kinase phosphorylating Raf-1 in physiological condition remains to be identi®ed.
Ha-Ras undergoes a series of posttranslational modi®cations including farnesylation at its unique Cterminal CAAX motif (reviewed in Casey, 1994) . The posttranslational modi®cations were shown to be essential for anchoring of Ras to the plasma membrane as well as for in vivo activation of Raf-1 (Willumsen et al., 1984; Hancock et al., 1990; Kikuchi and Williams, 1994) . The membrane-anchoring function has been implicated in a mechanism underlying the requirement of the modi®cations for Raf-1 activation. However, it is possible that the modifications may have another role in the process of Raf-1 activation.
Extensive mutational studies on Ras identi®ed amino acid residues whose substitutions abrogated various biological activities as well as the ability to associate with Raf-1 without aecting the guanine nucleotide-binding properties (reviewed in Marshall, 1993) . Most of these residues were concentrated in a region corresponding to the residues 32 ± 40 of mammalian Ras, designated`eector region', which corresponded to`switch I', one of the regions that assume signi®cantly dierent conformations between the GTP-and GDP-bound forms (Milburn et al., 1990; Pai et al., 1990) . On the other hand, the residues 26, 28, 31, 42, 45, 46, 48, 49 and 53 ,¯anking the eector region, were recently found to be critical for the Ras signaling even though they do not change their conformations upon GDP-GTP exchange (Marshall, 1993; Shirouzu et al., 1994; Fujita-Yoshigaki et al., 1995) . Thus, these residues which are likely to be involved in activation of Ras eectors, were designated the`activator region' (Marshall, 1993) or`constitutive eector region' (Fujita-Yoshigaki et al., 1995) .
In addition to the well characterized interaction between the Ras eector region and Ras-binding domain (RBD) (residues 51 ± 131) of Raf-1, which is essential for physical association between Ras and Raf-1, we and others showed that Ras interacts with cysteine-rich region (CRR) (residues 152 ± 184) of Raf-1 and that this interaction, albeit of a much weaker nature compared to the other, is required for Raf-1 activation (Brtva et al., 1995; Hu et al., 1995; Drugan et al., 1996) . The interaction was dependent on the posttranslational modi®cations of Ras and abolished by mutations, N26G and V45E, in the activator region (Hu et al., 1995) . These results led us to speculate that the association with Ras may have another critical role for Raf-1 activation than simple membrane recruitment. In the present study, we use a mutant Ha-Ras carrying the mutation V45E in the activator region to dissect Ras functions in Raf-1 activation.
Results
Measurement of direct association of Ha-Ras mutants with Raf-1
We ®rst examined direct association in vitro of the activator region mutant Ha-Ras V45E and the eector region mutant Ha-Ras D38N with the N-terminal region of Raf-1, Raf-1 (1 ± 206), encompassing both RBD and CRR. Wild-type Ha-Ras and its mutants all carried an activating mutation, valine for glycine substitution at position 12. Ha-Ras V45E , but not Ha-Ras D38N , bound directly to Raf-1 (1 ± 206) fused to maltose-binding protein (MBP) in a GTP-dependent manner as eciently as wild-type Ha-Ras (Figure 1a) . At the concentration of Ha-Ras used (100 nM), interaction with CRR did not appreciably aect the overall Ras binding to Raf-1 (1 ± 206), which is mostly contributed by the high anity interaction with RBD (Hu et al., 1995) . We also showed previously that Ha-Ras V45E could interact with the full length Raf-1 as eciently as wild-type Ha-Ras in Sf9 cells expressing both of the proteins (Shinkai et al., 1996) .
Translocation of Raf-1 to the membrane by Ha-Ras and its mutants
Next we examined whether Ha-Ras V45E was capable of recruiting Raf-1 to the membrane. When Raf-1 was coexpressed with wild-type Ha-Ras or Ha-Ras V45E in COS7 cells, Raf-1 was detected in almost equal amounts in both the cytosol and the membrane extract fractions, whereas Raf-1 remained almost exclusively in the cytosol fraction when it was expressed alone or coexpressed with Ha- Ras   D38N ( Figure 1b) . The amounts of wild-type Ha-Ras and its mutants expressed were almost equal (Figure 1b) . These results imply that the activator region mutant Ha-Ras V45E , but not the eector region mutant HaRas D38N , possessed the activities to associate with Raf-1 and to induce its translocation to the membrane as eciently as those of wild-type Ha-Ras. A slower migration upon SDS-polyacrylamide gel electrophoresis (PAGE) was observed for Raf-1 translocated to the membrane either by wild-type or Ha-Ras V45E compared to Raf-1 remained in the cytosol, suggesting that Raf-1 underwent some kind of phosphorylation concomitant with the translocation (Figure 1b 
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Figure 1 Membrane translocation and activation of Raf-1 by wild-type Ha-Ras and its mutants. (a) ten pmol each of wild-type Ha-Ras protein (WT) or that carrying the mutation D38N or V45E (D38N and V45E) were loaded with guanosine 5'-O-(2-thiodiphosphate) (GDPbS) (D) or guanosine 5'-O-(3-thiotriphosphate) (GTPgS) (T), and examined for association with MBP-Raf-1 (1 ± 206) (1 mg) immobilized on amylose resin. The bound Ha-Ras was fractionated by SDS ± PAGE (12% gel), followed by Western immunoblotting with anti-Ha-Ras antibody F235. The electrophoretic mobilities of wild-type Ha-Ras and its mutants dier one another as reported previously (Akasaka et al., 1996) . (b) COS7 cells, cotransfected with pH8-Raf-1 and either of pEF-BOS-HA (7) or those carrying the indicated Ha-ras cDNAs, were homogenized and separated into the cytosol and the membrane extract fractions. One-®fth aliquot each of the cytosol (C) and the membrane extract fraction (M) was separated by SDS ± PAGE (10% gel) and subjected to immunoblotting with anti-Raf-1 antibody (upper panel). The amounts of HA-tagged Ha-Ras in the membrane extract fractions were measured by immunoblotting with anti-Ha-Ras antibody (lower panel). (c) Raf-1 immunoprecipitated by antiRaf-1 antibody from the membrane extract fractions used in (b) was separated by SDS ± PAGE (10% gel) and subjected to Western immunoblotting with anti-Raf-1 antibody. (d) the immunoprecipitated Raf-1 was examined for the activity to induce phosphorylation of GST-KNERK as described under Materials and methods and the phosphorylated KNERK was detected by autoradiography (upper panel). The intensity of the KNERK bands were quanti®ed by BAS2000 bioimaging analyser (lower panel).
The results shown are representative of three independent experiments, giving equivalent results tyrosine phosphorylation (Ferrier et al., 1997) . It is presently unclear whether the mobility shift of Raf-1 correlates with its activity.
Measurement of the activity of Raf-1 translocated to the membrane
We examined the kinase activity of Raf-1 translocated to the membrane by wild-type Ha-Ras and its mutants as described in Materials and methods. Raf-1 immunoprecipitated by anti-Raf-1 antibody from the membrane extract fraction of COS7 cells was incubated with glutathione S-transferase-fusion protein of a kinase negative mutant of ERK2 (GST-KNERK) in the presence of GST-MEK and [g-32 P]ATP, and examined for its activity to induce phosphorylation of KNERK. Although almost equal amounts of Raf-1 were immunoprecipitated (Figure 1c) , Raf-1 translocated by Ha-Ras V45E had its activity reduced by 70% compared to that by wild-type ( Figure 1d ). As expected, Ha-Ras D38N , which was incapable of inducing translocation of Raf-1, yielded very little membrane-associated Raf-1 activity. To exclude the possibility that the observed dierence in the Raf-1 activation by wild-type Ha-Ras and Ha-Ras V45E might be accounted for by dierential stability of the Ras-Raf complex on the membrane, we next examined whether the translocated Raf-1 was still associated with Ha-Ras (Figure 2 ). When wild-type Ha-Ras or Ha-Ras V45E tagged with in¯uenza hemagglutinin (HA) epitope was coexpressed with Raf-1 in COS7 cells, the amount of Raf-1, extracted from the membrane fraction and immunoprecipitated with anti-HA antibody, was almost equal, indicating that the membrane-translocated Raf-1 was associated with Ha-Ras V45E as eciently as with wild-type Ha-Ras (Figure 2a) . Subsequently, the immunoprecipitated Raf-1 was subjected to measurement of the activity to induce phosphorylation of KNERK. As shown in Figure 2b , Raf-1 co-immunoprecipitated with Ha-Ras V45E was found to possess an attenuated activity corresponding to about 30% of that obtained with wild-type Ha-Ras, which is similar as observed with the whole membranetranslocated Raf-1.
Measurement of the activation of ERK2 by Ha-Ras mutants
To examine the activity of wild-type Ha-Ras and its mutants to stimulate the downstream MAP kinase cascade in vivo, FLAG-tagged ERK2 was expressed in COS7 cells along with wild-type Ha-Ras, Ha-Ras V45E or Ha-Ras D38N , immunoprecipitated with anti-FLAG antibody from the total cell lysate, and its activity was measured by phosphorylation of myelin basic protein (Figure 3) . Although equal amounts of ERK2 were immunoprecipitated (Figure 3a) , the activity of ERK2 coexpressed with Ha-Ras V45E was reduced by about 70% compared to that coexpressed with wild-type HaRas (Figure 3b ). Ha-Ras D38N exhibited very low activity also in this assay. These results indicated that the low activity of Raf-1 associated with Ha-Ras V45E , measured by the in vitro kinase assay, re¯ected its in vivo activity to activate the MAP kinase cascade.
Discussion
Based on the observation that forced membrane targeting of Raf-1, brought about by attachment of the polybasic region and the CAAX sequence of KiRas at its C-terminus (Raf-CAAX), resulted in Rasindependent activation of its activity, it has been proposed that the only major function of Ras in Raf-1 activation process is to recruit Raf-1 to the plasma membrane, where a separate activation event takes place (Leevers et al., 1994; Stokoe et al., 1994) . In the same line, the essential nature of the posttranslational modi®cations of Ras in Raf-1 activation has been interpreted in terms of their membrane-anchoring function. However, from these studies in which Raf-1 was translocated to the plasma membrane through arti®cial means, not through its physiological association with Ras, it has been impossible to rule out the possibilty that the association of Ras with Raf-1 may have another function in the process of Raf-1 , which retained a tight association with Raf-1 RBD through its intact effector region but lost the ability to exert its various biological activities (Marshall, 1993; Shirouzu et al., 1994; FujitaYoshigaki et al., 1995; Hu et al., 1995) , to dissect Ras function in Raf-1 activation other than membrane recruitment. It was found that Ha-Ras V45E associated with Raf-1 and induced membrane translocation of Raf-1 as eciently as wild-type Ha-Ras. However, the activity of this mutant to activate Raf-1 and thereby induce stimulation of the MAP kinase activity in COS7 cells was severely attenuated. These results clearly indicate that the Ras-dependent translocation to the plasma membrane is not sucient for the Rasdependent Raf-1 activation.
The mechanism for the weak activation of Raf-1 by Ha-Ras V45E is not clear. However, it is likely that physiological translocation of Raf-1 to the plasma membrane, through the interaction between the eector region of Ras and RBD, may be enough to activate Raf-1 to some extent by bringing it to the proximity of Raf-activating kinases on the membrane as in the case of Raf-CAAX. It was shown that oncogenic Src expressed in insect cells activates Raf-1 via direct phosphorylation on the tyrosine residues 340 and 341 (Fabian et al., 1993) . However, this activation appears to be independent of Ras since a mutation (R89L) of Raf-1, which abolished both its interaction with Ras and its activation by Ras, does not aect the ability of the oncogenic Src to activate Raf-1 (Fabian et al., 1994) . Also, other protein kinases such as ceramideactivated protein kinase (Ksr-1) (Yao et al., 1995; Zhang et al., 1997) , Tpl-2 (Patriotis et al., 1994) and protein kinase C (Kolch et al., 1993; Cai et al., 1997) can activate Raf-1 by phosphorylation. In addition to the phosphorylation events, arti®cial oligomerization of Raf-1 was reported to cause its activation (Farrar et al., 1996; Luo et al., 1996) . However, the role of these phenomena in the Ras-dependent activation process on the plasma membrane remains elusive at present.
Recently, Mineo et al. reported that physical association with Ras brought about further activation of Raf-CAAX, which had already been bound to the plasma membrane and partially activated independently of Ras (Mineo et al., 1997) . Although the method used for membrane recruitment of Raf-1 is not physiological, this report, together with ours, indicates clearly that the association with Ras plays a role in Raf-1 activation that is distinct from membrane recruitment. The mechanism by which association with Ras at the plasma membrane further activates Raf-1 remains to be clari®ed. It may involve the establishment of a speci®c conformational change of Raf-1 necessary for interaction with its activating kinases or other components of the signaling cascade, or for inducing oligomerization of Raf-1. Regardless of the mechanism, the results presented here indicated that Ras possesses another function necessary for full activation of Raf-1 than the simple recruitment of Raf-1 to the plasma membrane, that presumably depends upon the interaction between the activator region of Ras and CRR considering that Ha-Ras V45E selectively lost the activity to bind to CRR (Hu et al., 1995) . In this line, it may be interesting to note that the level of Raf-1 activation by Ha-Ras V45E , about 30% of that induced by wild-type Ha-Ras, is similar to that of a Raf-1 mutant carrying mutations (C165S, C168S) in the zinc ®nger of CRR compared to that of wild-type Raf-1 upon stimulation by epidermal growth factor (Luo et al., 1997) .
Materials and methods

Materials
Anti-Ha-Ras monoclonal antibody F235 (Oncogene Science Inc, Manhasset, NY), anti-Raf-1 polyclonal antibody C12 (Santa Cruz Biotechnology Inc, Santa Cruz, CA), anti-FLAG monoclonal antibody (Eastman Kodak), and anti-HA monoclonal antibody 12CA5 (Boehringer Mannheim) were used for immunoblot detection and immunoprecipitation of the respective proteins. The ECL immunodetection system (Amersham) was used for the signal development. Human Ha-ras cDNAs carrying various mutations were provided by S Yokoyama (University of Tokyo, Tokyo, Japan) and cloned into pEF-BOS-HA (Mizushima and Nagata, 1990) overexpressing the respective proteins as described previously (Akasaka et al., 1996) . Human c-raf-1 cDNA was cloned into pH8, an SV40-based expression vector constructed by us, possessing the Moloney murine leukemia virus long terminal repeat as a promoter. Escherichia coli expressing GST-MEK or GST-KNERK (Kikuchi and Williams, 1994) were provided by A Kikuchi (Hiroshima University, Hiroshima, Japan). The rat fulllength ERK2 cDNA was fused with synthetic oligonucleotides encoding the FLAG epitope (DYKDDDDK) and cloned into a mammalian expression vector pCMV5 (Andersson et al., 1989 
Ras binding assay
The in vitro binding assay of Ha-Ras and its mutant proteins to MBF-Raf-1 (1 ± 206) was carried out as described previously (Akasaka et al., 1996) .
Determination of subcellular localization of Raf-1 COS7 cells were cotransfected with pH8-Raf-1 and either of pEF-BOS-HA or those carrying various Ha-ras cDNAs. Thirty-two hours after transfection, the cells were transferred to serum-free media and further cultured for 16 h. Subsequently, the cells were harvested, washed with cold phosphate-buered saline and suspended in 500 ml of buer A (20 mM Tris/HCl pH 7.5, 5 mM MgCl 2 , 1 mM EGTA, 1 mM phenylmethylsulfonyl¯uoride, 20 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM sodium vanadate, and 20 mM b-glycerophosphate), followed by sonication and centrifugation at 700 g for 5 min to remove unbroken cells and nuclei. The cleared lysate was centrifuged at 100 000 g for 30 min, and the supernatant was used as the cytosol fraction. The resulting pellet was resuspended in 100 ml of buer A containing 1% Nonidet P-40, rocked for 1 h, and then centrifuged at 100 000 g for 30 min. The resulting supernatant was used as the membrane extract fraction. Aliquots of the cytosol and membrane extract fractions were subjected to SDS ± PAGE, blotted onto nitrocellulose ®lters and probed with suitable antibodies. For co-immunoprecipitation assays, aliquots of the membrane extract fraction were immunoprecipitated with anti-HA antibody and protein G-agarose. The immunoprecipitates were subjected to SDS ± PAGE, followed by immunoblotting with suitable antibodies, or to determination of the Raf-1 activity as described below.
Assays for Ha-Ras-dependent activation of Raf-1
An aliquot of the membrane extract fraction of COS7 cells, cotransfected with pH8-Raf-1 and each of pEF-BOS-HAHa-Ras mutants, was immunoprecipitated with anti-Raf-1 antibody or anti-HA antibody. The immunoprecipitate was incubated with GST-MEK (0.1 mg) and GST-KNERK (1 mg) in 30 ml of kinase reaction mixture (20 mM Tris/ HCl pH 7.5, 10 mM MgCl 2 , 20 mM b-glycerophosphate, and 50 mM [g-32 P]ATP (2000 c.p.m./pmol)) for 10 min at 308C as described (Kikuchi and Williams, 1994; Akasaka et al., 1996) . After the incubation, the reaction was stopped by the addition of Laemmli's loading buer (Laemmli, 1970) , fractionated by SDS ± PAGE, and subjected to visualization and quanti®cation of the phosphorylated proteins using BAS2000 bioimaging analyser (Fujix, Tokyo, Japan).
Assays for Ha-Ras-dependent activation of ERK2
COS7 cells, cotransfected with pCMV-FLAG-ERK2 and each of pEF-BOS-HA-Ha-Ras mutants, were washed with cold phosphate-buered saline and lysed in buer B (20 mM Tris/HCl pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml leupeptin, 1 mM sodium vanadate, and 20 mM bglycerophosphate). The lysate was immunoprecipitated with anti-FLAG antibody. The immunoprecipitate was incubated with myelin basic protein (2 mg) in 20 ml of kinase reaction mixture (20 mM Tris/HCl pH 7.5, 5 mM MgCl 2 , 20 mM b-glycerophosphate, 50 mM [g-32 P]ATP (3000 c.p.m./pmol)) for 20 min at 308C as described (Minden et al., 1995) . After the incubation, phosphorylated proteins were quanti®ed as described above.
